Why NAMS? NewAmsterdam Pharma Company N.V Analysis, Price & AI Insights | Whystock
NAMS
$28.43-0.13 (-0.46%)
Market ClosedLast close May 1
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease.